|
|
Article: Calypte Biomedical Announces Collaboration with Wampole Laboratories and Clinical Reference Laboratory in National Urine-Based HIV and STD Testing Service.
- Article from:
- Business Wire
- Article date:
- January 24, 2000
CopyrightCOPYRIGHT 2000 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business/Health Editors &Medical Writers
ALAMEDA, CA--(BUSINESS WIRE)--Jan. 24, 2000
Revolutionary Service Offers Fast, Affordable, Painless Testing Method for STDs
Calypte Biomedical Corporation (NASDAQ:CALY) announced today that it has entered into a collaboration with Wampole Laboratories, a division of Carter Wallace, Inc. (NYSE:CAR), and Clinical Reference Laboratory (CRL) to launch a new national urine-based testing service for HIV-1 antibody, chlamydia, and gonorrhea.
The new service, called Sentinel, is a painless, non-invasive, urine-based sampling method designed to identify HIV-1 antibody and the chlamydia and gonorrhea ...